The powdered concentrate version of the drug infliximab is used to reconstitute the medication into a solution for intravenous infusion. It is frequently offered for sale under the name "Remicade."
An anti-inflammatory protein known as tumour necrosis factor-alpha (TNF-alpha) is the target of the monoclonal antibody infliximab. In diseases where inflammation plays a substantial role, Infliximab helps to decrease inflammation and dampen the immune response by blocking TNF-alpha.
1. IBD (Inflammatory Bowel Disease): Infliximab is used to treat mild to severe cases of IBD, such as Crohn's illness and ulcerative colitis.
2. It is used to treat moderate to severe cases of rheumatoid arthritis (RA) that have not responded well to previous drugs.
3. Ankylosing Spondylitis: Ankylosing spondylitis is a form of inflammatory arthritis that affects the spine and major joints. Infliximab is used to treat this condition.
4. It is used to treat psoriatic arthritis, a kind of arthritis that develops in some people who have psoriasis.
5. Adults with moderate to severe plaque psoriasis are treated with infliximab.
Typically, sterile water is used to reconstitute infliximab powder for concentration, creating a solution that is subsequently given as an intravenous (IV) infusion. The infusion is often administered over a period of time in a medical setting under the guidance of a healthcare expert.
Depending on the particular illness being treated, the patient's reaction to treatment, and the healthcare provider's suggestion, the dosage and frequency of Infliximab infusions may change.
Infliximab may have side effects, which might vary from person to person as with any medication. Infusion responses, headaches, weariness, respiratory infections, and an increased risk of certain infections are examples of common adverse effects. Additionally, infliximab can impact the immune system and raise the chance of developing certain diseases like cancer and tuberculosis.
While taking Infliximab medication, patients must be continuously watched by their healthcare team in order to manage and treat any potential adverse effects.
It's crucial to speak with a licenced healthcare professional if you have questions about Infliximab or have been prescribed the drug in order to receive thorough information and advice catered to your unique medical requirements.
MEHADIA TRADELINKS
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |